Michael Narachi
Direktor/Vorstandsmitglied bei ULTRAGENYX PHARMACEUTICAL INC.
Vermögen: 1 Mio $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Michael Narachi
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
224
| Public Company | Pharmaceuticals: Major | 224 |
Public Company | Pharmaceuticals: Major | 50 | |
Subsidiary | Pharmaceuticals: Major | 46 | |
Subsidiary | Pharmaceuticals: Major | 36 | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.
18
| Non-Profit Organization | Pharmaceuticals: Major | 18 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA.
13
| Extinct | Biotechnology | 13 |
Naryx Pharma, Inc.
Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Naryx Pharma, Inc. developd products for the treatment of chronic sinusitis. Its products were focused on inhaled, nebulizer, intranasal drug formulations. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focused on development of inhaled, nebulized, and intranasal drug formulations. The company was founded in 1999 and was headquartered in Carpinteria, CA.
1
| Extinct | Pharmaceuticals: Major | 1 |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA.
1
| Holding Company | Medical Specialties | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Narachi
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Amgen Ventures LLC
Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital firm, a subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Investment Managers | General Counsel Chief Executive Officer Director/Board Member General Counsel Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal Compliance Officer Chief Administrative Officer Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
DIMENSION THERAPEUTICS INC | Biotechnology | President Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
The Johns Hopkins University | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree | |
University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
INTERMUNE INC | Biotechnology | Chief Operating Officer Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Director/Board Member Director/Board Member | |
United States Naval Academy | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
MACROGENICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Chief Executive Officer | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member Director/Board Member | |
ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Operating Officer | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
ALIGN TECHNOLOGY, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
ALLERGAN, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
University of Michigan | College/University | Chief Tech/Sci/R&D Officer Undergraduate Degree Undergraduate Degree | |
University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Director/Board Member Director/Board Member Undergraduate Degree | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer President | |
DiObex, Inc.
DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
State University of New York at Buffalo | College/University | Masters Business Admin Graduate Degree | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Director/Board Member | |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member Director/Board Member | |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
Vereinigte Staaten | 51 |
Sektoral
Health Technology | 31 |
Consumer Services | 16 |
Commercial Services | 4 |
Finance | 2 |
Retail Trade | 2 |
Operativ
Director/Board Member | 896 |
Corporate Officer/Principal | 287 |
Independent Dir/Board Member | 275 |
Chairman | 152 |
Chief Executive Officer | 110 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Powell | 48 |
Eckard Weber | 46 |
Gil Omenn | 42 |
Jerry D. Choate | 41 |
Brian H. Dovey | 40 |
Todd Foley | 38 |
Frank J. Biondi | 36 |
Barbara Dalton | 35 |
Joseph Lacob | 35 |
Dan Omstead | 33 |
George Scangos | 33 |
Leonard Schaeffer | 32 |
Marc M. P. de Garidel | 32 |
Carl Johan Kördel | 31 |
Kathryn Falberg | 30 |
- Börse
- Insiders
- Michael Narachi
- Unternehmensverbindungen